MSLN and neoplasm: It has also been observed that serum SMRP levels are related to the International Federation of Gynaecology and Obstetric (FIGO) system’s pathological staging and the grading of neoplasms, demonstrating that high serum levels of mesothelin may be indicative of tumour progression and poor survival [23,24,25].